Creative Biogene Releases Custom Lentivirus Production Services to Support Gene Delivery

Creative Biogene announced the release of its custom lentivirus production service including integrating lentivirus and integrase-deficient lentivirus (IDLV) to further satisfy gene delivery needs.

New York, USA – September 6, 2022 – With over 10 years of experience, Creative Biogene remains one of the global leaders in gene editing and viral services. The professional team is dedicated to offering a range of research tools for genome and proteome analysis which include cDNA clones, antibodies, recombinant proteins and custom services. Recently, Creative Biogene announced the release of its custom lentivirus production service including integrating lentivirus (ILV) and integrase-deficient lentivirus (IDLV) to further satisfy gene delivery needs.

Creative Biogene’s lentivirus packaging team has rich experience in lentivirus-related work, and has carried out research on improving the ability of lentivirus to carry foreign genes, improving the affinity of lentivirus to cells of different tissue sources, and improving the yield and titer of lentivirus. system optimization. The lentivirus constructed by Creative Biogene proved to be able to efficiently infect T cells by FACS. Creative Biogene provides a one-stop service for ultra-high-titer lentiviral production services for CAR-T cell therapy.

With high-quality IDLV production services and conjugate synthesis platforms, Creative Biogene can provide comprehensive services from DNA synthesis, construction of lentiviral expression plasmids with promoters or reporter genes of interest, to final virus production. Creative Biogene is able to provide high titer IDLVs that are concentrated and purified by ura centrifugation for in vivo animal injection. Creative Biogene can provide all-in-one services from DNA synthesis to virus production and can customize lentiviral transfer plasmids to suit each specific project, which enables researchers to perform off-target analysis of ZFN, TALEN, CRISPR/Cas9 systems through IDLV capture technology, and further facilitate gene therapy research.

With years of experience in lentivirus research, Creative Biogene provides convenient and efficient services for research on promoter regulation, target gene overexpression, and gene silencing. Using the innovative platform “CLPS” (Creative Lentiviral Packaging System), Creative Biogene delivers highly safe and efficient gene delivery from lentiviruses generated from the “CLPS” platform to almost all cell types and entire model organisms. Creative Biogene’s one-stop lentiviral service can deliver transgenes (cDNA, shRNA, miRNA, etc.) into a variety of cells and generate stable cell lines for durable high-level expression, cloning the gene of interest into an appropriate lentiviral transfer plasmid.

“We have state-of-the-art facilities and experienced staff to assist in all areas of viral vector design and construction, as well as a rapid turnaround for virus production. Our custom virus service is distinguished by consistently high titers and high delivered virus counts.” said Marcia Brady, the marketing director of Creative Biogene, she also added, “Our in-house experts are constantly working to develop tools and innovative solutions for the biological research community.”

About Creative Biogene

Creative Biogene is a top-of-its-kind company that holds a leading position and is committed to accelerating the development of human science through biotechnology, offering innovative technologies, products, unique tools and services for research discoveries and product development. With more than 10 years of experience and in-house experts, Creative Biogene has become a well-recognized industry leader to support researchers worldwide.

Media Contact
Company Name: Creative Biogene
Contact Person: Marcia Brady
Email: Send Email
Phone: 1-631-386-8241
Country: United States